Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-12-01 Purchase |
2021-12-10 6:50 pm |
Odonate Therapeutics Inc. | ODT | EcoR1 Capital LLC 10% Owner |
185,941 | $1.66 | $308,662 | 0 (Indirect) |
View |
| 2021-12-01 Sale |
2021-12-10 6:50 pm |
Odonate Therapeutics Inc. | ODT | EcoR1 Capital LLC 10% Owner |
5,887,610 | $1.6545 | $9,741,063 | 0 (Indirect) |
View |
| 2021-03-31 Purchase |
2021-11-30 6:07 pm |
Nuvation Bio Inc. | NUVB | NODELMAN OLEG EcoR1 Capital LLC EcoR1 Capital Fund L.P. EcoR1 Capital Fund Qualified L.P. EcoR1 Venture Opportunity Fund LP Biotech Opportunity GP LLC Director |
393,168 | $8.8887 | $3,494,733 | 6,534,868 (Indirect) |
View |
| 2021-03-31 Sale |
2021-11-30 6:07 pm |
Nuvation Bio Inc. | NUVB | NODELMAN OLEG EcoR1 Capital LLC EcoR1 Capital Fund L.P. EcoR1 Capital Fund Qualified L.P. EcoR1 Venture Opportunity Fund LP Biotech Opportunity GP LLC Director |
208,142 | $9.9578 | $2,072,642 | 6,534,868 (Indirect) |
View |
| 2021-09-30 Sale |
2021-10-01 7:39 pm |
Corvus Pharmaceuticals Inc. | CRVS | EcoR1 Capital LLC 10% Owner |
5,000,000 | $5.012 | $25,059,900 | 81,077 (Indirect) |
View |
| 2021-04-30 Purchase |
2021-05-04 4:51 pm |
ANAPTYSBIO INC | ANAB | EcoR1 Capital LLC NODELMAN OLEG Director 10% Owner |
221,500 | $23.24 | $5,147,444 | 7,520,424 (Indirect) |
View |
| 2021-04-23 Purchase |
2021-04-27 6:23 pm |
ANAPTYSBIO INC | ANAB | EcoR1 Capital LLC NODELMAN OLEG Director 10% Owner |
147,300 | $23.63 | $3,480,233 | 7,298,924 (Indirect) |
View |
| 2021-04-09 Purchase |
2021-04-13 5:55 pm |
Nuvation Bio Inc. | NUVB | NODELMAN OLEG EcoR1 Capital LLC EcoR1 Capital Fund L.P. EcoR1 Capital Fund Qualified L.P. EcoR1 Venture Opportunity Fund LP EcoR1 Panacea Holdings LLC Biotech Opportunity GP LLC Director |
464,500 | $9.8915 | $4,594,594 | 6,721,252 (Indirect) |
View |
| 2021-04-09 Purchase |
2021-04-13 3:10 pm |
Panacea Acquisition Corp. II | PANA | EcoR1 Panacea Holdings II LLC NODELMAN OLEG EcoR1 Capital Fund L.P. EcoR1 Capital Fund Qualified L.P. EcoR1 Venture Opportunity Fund LP EcoR1 Capital LLC Biotech Opportunity GP LLC Director 10% Owner |
545,000 | $10 | $5,450,000 | 545,000 (Direct) |
View |
| 2021-03-24 Purchase |
2021-03-25 11:14 am |
PROTHENA CORP PUBLIC LTD CO | PRTA | EcoR1 Capital LLC 10% Owner |
875,000 | $20.75 | $18,156,250 | 11,034,280 (Indirect) |
View |
| 2021-03-08 Purchase |
2021-03-10 5:53 pm |
ANAPTYSBIO INC | ANAB | EcoR1 Capital LLC 10% Owner |
3,308,800 | $18.93 | $62,622,736 | 7,151,624 (Indirect) |
View |
| 2021-02-23 Purchase |
2021-02-25 6:00 pm |
PROTHENA CORP PUBLIC LTD CO | PRTA | EcoR1 Capital LLC 10% Owner |
55,200 | $21.24 | $1,172,385 | 10,159,280 (Indirect) |
View |
| 2021-02-23 Purchase |
2021-02-25 5:58 pm |
ANAPTYSBIO INC | ANAB | EcoR1 Capital LLC 10% Owner |
29,500 | $25.48 | $751,657 | 3,842,824 (Indirect) |
View |
| 2021-02-18 Purchase(A) |
2021-02-23 3:57 pm |
PROTHENA CORP PUBLIC LTD CO | PRTA | EcoR1 Capital LLC 10% Owner |
44,100 | $23.65 | $1,043,075 | 10,104,080 (Indirect) |
View |
| 2021-02-18 Purchase |
2021-02-22 4:24 pm |
PROTHENA CORP PUBLIC LTD CO | PRTA | EcoR1 Capital LLC 10% Owner |
44,100 | $3.6758 | $162,103 | 10,104,080 (Indirect) |
View |
| 2021-02-12 Purchase |
2021-02-17 7:14 pm |
PROTHENA CORP PUBLIC LTD CO | PRTA | EcoR1 Capital LLC 10% Owner |
633,340 | $21.56 | $13,657,270 | 10,062,480 (Indirect) |
View |
| 2020-09-01 Sale |
2020-09-03 4:17 pm |
Surface Oncology Inc. | SURF | EcoR1 Capital LLC 10% Owner |
332,780 | $7.1419 | $2,376,681 | 4,701,081 (Indirect) |
View |
| 2020-07-06 Purchase |
2020-07-06 5:06 pm |
Panacea Acquisition Corp | PANA | EcoR1 Panacea Holdings LLC NODELMAN OLEG EcoR1 Capital Fund L.P. EcoR1 Capital Fund Qualified L.P. EcoR1 Venture Opportunity Fund LP EcoR1 Capital LLC Biotech Opportunity GP LLC Director 10% Owner |
390,000 | $10 | $3,900,000 | 390,000 (Direct) |
View |
| 2020-06-30 Purchase |
2020-07-02 5:20 pm |
Akouos Inc. | AKUS | EcoR1 Capital LLC 10% Owner |
1,176,000 | $17 | $19,992,000 | 1,975,984 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2021-11-18 1:00 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | EcoR1 Capital LLC 10% Owner |
0 | $0 | 5,701,669 (Indirect) |
View |
Ownership |
2021-09-22 3:30 pm |
N/A N/A |
Corvus Pharmaceuticals Inc. | CRVS | EcoR1 Capital LLC 10% Owner |
0 | $0 | 5,081,077 (Indirect) |
View |
| 2021-06-18 Exercise |
2021-06-22 5:05 pm |
2021-02-17 2021-06-18 |
PROTHENA CORP PUBLIC LTD CO | PRTA | EcoR1 Capital LLC 10% Owner |
2,500 | $0 | 11,284,280 (Indirect) |
View |
| 2021-06-18 Exercise |
2021-06-22 5:05 pm |
N/A N/A |
PROTHENA CORP PUBLIC LTD CO | PRTA | EcoR1 Capital LLC 10% Owner |
250,000 | $30 | 11,284,280 (Indirect) |
View |
| 2021-02-10 Conversion |
2021-02-12 8:59 pm |
N/A N/A |
Nuvation Bio Inc. | NUVB | NODELMAN OLEG EcoR1 Panacea Holdings LLC EcoR1 Capital Fund L.P. EcoR1 Capital Fund Qualified L.P. EcoR1 Venture Opportunity Fund LP EcoR1 Capital LLC Biotech Opportunity GP LLC Director 10% Owner |
2,775,000 | $0 | 3,163,960 (Indirect) |
View |
| 2021-02-10 Option Award |
2021-02-12 8:59 pm |
N/A N/A |
Nuvation Bio Inc. | NUVB | NODELMAN OLEG EcoR1 Panacea Holdings LLC EcoR1 Capital Fund L.P. EcoR1 Capital Fund Qualified L.P. EcoR1 Venture Opportunity Fund LP EcoR1 Capital LLC Biotech Opportunity GP LLC Director 10% Owner |
2,500,000 | $10 | 3,163,960 (Indirect) |
View |
| 2021-02-10 Option Award |
2021-02-12 8:59 pm |
2021-07-06 N/A |
Nuvation Bio Inc. | NUVB | NODELMAN OLEG EcoR1 Panacea Holdings LLC EcoR1 Capital Fund L.P. EcoR1 Capital Fund Qualified L.P. EcoR1 Venture Opportunity Fund LP EcoR1 Capital LLC Biotech Opportunity GP LLC Director 10% Owner |
8,545,350 | $0 | 3,163,960 (Indirect) |
View |
Ownership |
2021-01-14 4:39 pm |
N/A N/A |
ANAPTYSBIO INC | ANAB | EcoR1 Capital LLC 10% Owner |
0 | $0 | 3,813,324 (Indirect) |
View |
| 2020-06-30 Conversion |
2020-07-02 5:20 pm |
N/A N/A |
Akouos Inc. | AKUS | EcoR1 Capital LLC 10% Owner |
17,658,060 | $0 | 1,975,984 (Indirect) |
View |
Ownership |
2020-06-30 6:02 pm |
N/A N/A |
Panacea Acquisition Corp | PANA | EcoR1 Panacea Holdings LLC NODELMAN OLEG EcoR1 Capital Fund L.P. EcoR1 Capital Fund Qualified L.P. EcoR1 Venture Opportunity Fund LP EcoR1 Capital LLC Biotech Opportunity GP LLC Director 10% Owner |
0 | $0 | 2,775,000 (Direct) |
View |
Ownership |
2020-06-25 6:25 pm |
N/A N/A |
Akouos Inc. | AKUS | EcoR1 Capital LLC 10% Owner |
0 | $0 | 799,984 (Indirect) |
View |
Ownership |
2020-05-29 4:23 pm |
N/A N/A |
Surface Oncology Inc. | SURF | EcoR1 Capital LLC 10% Owner |
0 | $0 | 5,033,861 (Indirect) |
View |